Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

11.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Electron Carriers01:24

Electron Carriers

75.9K
Electron carriers can be thought of as electron shuttles. These compounds can easily accept electrons (i.e., be reduced) or lose them (i.e., be oxidized). They play an essential role in energy production because cellular respiration is contingent on the flow of electrons.
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
75.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuberculous tenosynovitis and bursitis: imaging findings in 21 cases.

Radiology·1996
Same author

Recombinant mitotoxin basic fibroblast growth factor-saporin reduces venous anastomotic intimal hyperplasia in the arteriovenous graft.

Circulation·1996
Same author

Measurement of urinary estrogen metabolites using a monoclonal enzyme-linked immunoassay kit: assay performance and feasibility for epidemiological studies.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·1996
Same author

Differences in cholinergic responses from outer hair cells of rat and guinea pig.

Hearing research·1996
Same author

Pharmacokinetics of retinoids in women after meal consumption or vitamin A supplementation.

Journal of clinical pharmacology·1996
Same author

Determination of the amino acid residue involved in [3H]beta-funaltrexamine covalent binding in the cloned rat mu-opioid receptor.

The Journal of biological chemistry·1996

Related Experiment Video

Updated: Apr 29, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

10.2K

Nanocarrier: a potential tool for future antioxidant therapy.

L Du1, J Li, C Chen

  • 1State Key Laboratory for Structural Chemistry of Unstable and Stable Species, Center for Molecular Science, Institute of Chemistry, Chinese Academy of Sciences , Beijing , P. R. China.

Free Radical Research
|May 23, 2014
PubMed
Summary

Nanoantioxidants, using nanocarriers to deliver antioxidants, can overcome poor bioavailability and biocompatibility issues. This review explores their potential for treating oxidative stress-related diseases and clinical applications.

Keywords:
antioxidantsdrug deliveryfree radicalnanoparticlesoxidative stress

More Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

8.1K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

5.3K

Related Experiment Videos

Last Updated: Apr 29, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

10.2K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

8.1K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

5.3K

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Pharmacology

Background:

  • Oxidative stress contributes to various diseases.
  • Antioxidants show therapeutic promise but suffer from poor bioavailability and biocompatibility.
  • Nanomaterials offer a solution for enhanced antioxidant delivery.

Purpose of the Study:

  • To review the application of nanocarriers for antioxidant delivery.
  • To discuss the enhancement of antioxidant activity by nanoantioxidants.
  • To suggest future research for clinical translation of nanoantioxidants.

Main Methods:

  • Literature review of nanocarrier-based antioxidant delivery systems.
  • Analysis of studies demonstrating enhanced antioxidant efficacy.
  • Identification of challenges and opportunities for clinical application.

Main Results:

  • Nanocarriers improve antioxidant bioavailability and biocompatibility.
  • Encapsulation or covalent linking with nanomaterials creates effective nanoantioxidants.
  • Nanoantioxidants demonstrate enhanced therapeutic potential for oxidative stress.

Conclusions:

  • Nanoantioxidants represent a promising strategy to overcome limitations of conventional antioxidants.
  • Further research is needed to advance nanoantioxidant technology towards clinical use.
  • Nanotechnology holds significant potential for treating diseases associated with oxidative stress.